ACCESSION: MSBNK-SMB_Measured-HSA001P0145004
RECORD_TITLE: Characterized; N,N'-ethylenedi(diacetamide); LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 165
COMMENT: RAW_SPEC {'18_posi_11820': {'bp': 184175.0, 'sum': 387500.0}, '5_posi_11192': {'bp': 121314.0, 'sum': 232120.0}, 'BLK02_11443': {'bp': 122288.0, 'sum': 286571.0}, '2_posi_11255': {'bp': 123447.0, 'sum': 256791.0}, '14_posi_11318': {'bp': 123557.0, 'sum': 269511.0}, '19_posi_11339': {'bp': 130450.0, 'sum': 266878.0}, '5_posi_11969': {'bp': 131359.0, 'sum': 253944.0}, '15_posi_11947': {'bp': 132312.0, 'sum': 272641.0}, 'BLK02_11759': {'bp': 135408.0, 'sum': 292800.0}, '9_posi_11882': {'bp': 136978.0, 'sum': 264965.0}, '19_posi_12095': {'bp': 137898.0, 'sum': 269296.0}, '5_posi_11780': {'bp': 146032.0, 'sum': 306778.0}, '5_posi_12072': {'bp': 146227.0, 'sum': 283895.0}, '15_posi_11695': {'bp': 159780.0, 'sum': 321545.0}, '7_posi_11906': {'bp': 109433.0, 'sum': 250135.0}, 'ProcedureBlank_11591': {'bp': 110243.0, 'sum': 229109.0}, '5_posi_11567': {'bp': 114577.0, 'sum': 241537.0}, '10_posi_11255': {'bp': 118694.0, 'sum': 259954.0}, 'BLK02_11943': {'bp': 132384.0, 'sum': 305519.0}, '15_posi_11863': {'bp': 134714.0, 'sum': 268397.0}, '5_posi_12155': {'bp': 134871.0, 'sum': 299411.0}, '14_posi_11611': {'bp': 135995.0, 'sum': 274739.0}, '4_posi_12157': {'bp': 136205.0, 'sum': 287596.0}, '17_posi_11275': {'bp': 145363.0, 'sum': 304647.0}, '18_posi_11566': {'bp': 152743.0, 'sum': 309441.0}, '1_posi_12030': {'bp': 155078.0, 'sum': 304214.0}, '7_posi_11295': {'bp': 102387.0, 'sum': 219959.0}, '6_posi_12389': {'bp': 118610.0, 'sum': 240586.0}, '1_posi_12325': {'bp': 122627.0, 'sum': 274261.0}, '6_posi_11717': {'bp': 124213.0, 'sum': 262476.0}, '14_posi_11401': {'bp': 128549.0, 'sum': 277633.0}, '11_posi_12325': {'bp': 134640.0, 'sum': 290537.0}, '11_posi_12515': {'bp': 138401.0, 'sum': 272311.0}, '11_posi_12179': {'bp': 139011.0, 'sum': 298626.0}, '12_posi_11756': {'bp': 140320.0, 'sum': 275437.0}, '18_posi_12052': {'bp': 144810.0, 'sum': 270014.0}, 'BLK02_12494': {'bp': 152449.0, 'sum': 345208.0}, '10_posi_12368': {'bp': 160490.0, 'sum': 324471.0}, '8_posi_12345': {'bp': 161610.0, 'sum': 334120.0}, '2_posi_11948': {'bp': 163133.0, 'sum': 313921.0}, '13_posi_11885': {'bp': 163708.0, 'sum': 327517.0}, '18_posi_11945': {'bp': 166142.0, 'sum': 325672.0}, '1_posi_12242': {'bp': 110860.0, 'sum': 226630.0}, '8_posi_11633': {'bp': 113303.0, 'sum': 253915.0}, '3_posi_11611': {'bp': 117421.0, 'sum': 242612.0}, '18_posi_11083': {'bp': 118174.0, 'sum': 263781.0}, '3_posi_12535': {'bp': 122754.0, 'sum': 279163.0}, '11_posi_12094': {'bp': 123500.0, 'sum': 252938.0}, '5_posi_12367': {'bp': 126103.0, 'sum': 268197.0}, '6_posi_12053': {'bp': 127759.0, 'sum': 279340.0}, '14_posi_11171': {'bp': 128288.0, 'sum': 267973.0}, '19_posi_11821': {'bp': 128760.0, 'sum': 287186.0}, '16_posi_12114': {'bp': 136287.0, 'sum': 278433.0}, '18_posi_11275': {'bp': 137937.0, 'sum': 293300.0}, '10_posi_11861': {'bp': 139550.0, 'sum': 291002.0}, '2_posi_11546': {'bp': 139938.0, 'sum': 308341.0}, '13_posi_12200': {'bp': 142072.0, 'sum': 302395.0}, '16_posi_11465': {'bp': 142964.0, 'sum': 306965.0}, '19_posi_11927': {'bp': 146357.0, 'sum': 309069.0}, '17_posi_12323': {'bp': 146959.0, 'sum': 319456.0}, '6_posi_12471': {'bp': 149214.0, 'sum': 290667.0}, '10_posi_11568': {'bp': 150424.0, 'sum': 298123.0}, '18_posi_12533': {'bp': 150944.0, 'sum': 300788.0}, '17_posi_11611': {'bp': 152269.0, 'sum': 288880.0}, '14_posi_11486': {'bp': 152375.0, 'sum': 306734.0}, '17_posi_11989': {'bp': 154764.0, 'sum': 328757.0}, '4_posi_11759': {'bp': 155390.0, 'sum': 316898.0}, '16_posi_11694': {'bp': 156905.0, 'sum': 310052.0}, '18_posi_11379': {'bp': 167439.0, 'sum': 306003.0}, '3_posi_11232': {'bp': 170292.0, 'sum': 347254.0}, '15_posi_12116': {'bp': 180870.0, 'sum': 371243.0}, '6_posi_11209': {'bp': 110970.0, 'sum': 250545.0}, '11_posi_11842': {'bp': 121057.0, 'sum': 269026.0}, '11_posi_11233': {'bp': 122488.0, 'sum': 265081.0}, '6_posi_11525': {'bp': 123891.0, 'sum': 273907.0}, '5_posi_11654': {'bp': 125077.0, 'sum': 250904.0}, '9_posi_11696': {'bp': 126260.0, 'sum': 275418.0}, '7_posi_11780': {'bp': 127088.0, 'sum': 245813.0}, '9_posi_11486': {'bp': 132625.0, 'sum': 276982.0}, '12_posi_11549': {'bp': 132938.0, 'sum': 272342.0}, '9_posi_12200': {'bp': 133031.0, 'sum': 264904.0}, '18_posi_11484': {'bp': 133081.0, 'sum': 257431.0}, '2_posi_12325': {'bp': 135029.0, 'sum': 294959.0}, '12_posi_11402': {'bp': 137109.0, 'sum': 292702.0}, '7_posi_11675': {'bp': 142275.0, 'sum': 281479.0}, '11_posi_11756': {'bp': 142764.0, 'sum': 289707.0}, '15_posi_12367': {'bp': 146534.0, 'sum': 276303.0}, '19_posi_12262': {'bp': 146559.0, 'sum': 301492.0}, '5_posi_12236': {'bp': 154583.0, 'sum': 303974.0}, '17_posi_12197': {'bp': 160608.0, 'sum': 329743.0}, '16_posi_11926': {'bp': 170589.0, 'sum': 346343.0}, '9_posi_12473': {'bp': 124566.0, 'sum': 259585.0}, '8_posi_12431': {'bp': 126933.0, 'sum': 277873.0}, '7_posi_12389': {'bp': 127259.0, 'sum': 272537.0}, '18_posi_12284': {'bp': 138368.0, 'sum': 263578.0}, '2_posi_12493': {'bp': 139803.0, 'sum': 277233.0}, '3_posi_11948': {'bp': 141895.0, 'sum': 292864.0}, '16_posi_12326': {'bp': 146657.0, 'sum': 291464.0}, '16_posi_12032': {'bp': 150724.0, 'sum': 300911.0}, '17_posi_12114': {'bp': 151691.0, 'sum': 303253.0}, '2_posi_11801': {'bp': 151711.0, 'sum': 295928.0}, '13_posi_12387': {'bp': 156501.0, 'sum': 282205.0}, '15_posi_11570': {'bp': 158679.0, 'sum': 332198.0}, '18_posi_11673': {'bp': 164246.0, 'sum': 321808.0}, '9_posi_11990': {'bp': 112956.0, 'sum': 250281.0}, '2_posi_11150': {'bp': 118460.0, 'sum': 274490.0}, '11_posi_11461': {'bp': 118543.0, 'sum': 274918.0}, '7_posi_12263': {'bp': 122409.0, 'sum': 255151.0}, '7_posi_12030': {'bp': 127289.0, 'sum': 260195.0}, '15_posi_11171': {'bp': 130525.0, 'sum': 290647.0}, '16_posi_11107': {'bp': 131330.0, 'sum': 284307.0}, '17_posi_11779': {'bp': 132792.0, 'sum': 278725.0}, '12_posi_12221': {'bp': 132934.0, 'sum': 288332.0}, '8_posi_11758': {'bp': 152693.0, 'sum': 315279.0}, '10_posi_12515': {'bp': 162965.0, 'sum': 317941.0}, '19_posi_11441': {'bp': 118082.0, 'sum': 237486.0}, '10_posi_11947': {'bp': 133829.0, 'sum': 276621.0}, '10_posi_12053': {'bp': 137774.0, 'sum': 292810.0}, '16_posi_11568': {'bp': 140351.0, 'sum': 285297.0}, '16_posi_11359': {'bp': 140878.0, 'sum': 286268.0}, '16_posi_11212': {'bp': 143383.0, 'sum': 285749.0}, '10_posi_11759': {'bp': 157067.0, 'sum': 336112.0}, '19_posi_11231': {'bp': 169874.0, 'sum': 343177.0}, '17_posi_11864': {'bp': 174006.0, 'sum': 331875.0}, '6_posi_11294': {'bp': 128372.0, 'sum': 254933.0}, '7_posi_12112': {'bp': 135317.0, 'sum': 269604.0}, '7_posi_11444': {'bp': 136003.0, 'sum': 262420.0}, '6_posi_12220': {'bp': 136012.0, 'sum': 263430.0}, '8_posi_11297': {'bp': 137590.0, 'sum': 305645.0}, '3_posi_12095': {'bp': 164442.0, 'sum': 346051.0}, '9_posi_12282': {'bp': 133156.0, 'sum': 302723.0}, '19_posi_11145': {'bp': 141287.0, 'sum': 297918.0}, '13_posi_11778': {'bp': 154379.0, 'sum': 311698.0}, '16_posi_12489': {'bp': 164734.0, 'sum': 331591.0}, '18_posi_12366': {'bp': 163473.0, 'sum': 340134.0}, 'ProcedureBlank_12179': {'bp': 147114.0, 'sum': 309997.0}, '12_posi_11255': {'bp': 142316.0, 'sum': 288644.0}, '14_posi_11864': {'bp': 137738.0, 'sum': 273683.0}, 'ProcedureBlank_11780': {'bp': 135436.0, 'sum': 268292.0}, 'BLK02_11339': {'bp': 135002.0, 'sum': 298994.0}, 'BLK02_11841': {'bp': 134299.0, 'sum': 333387.0}, '5_posi_12511': {'bp': 132326.0, 'sum': 268714.0}, '12_posi_11150': {'bp': 131657.0, 'sum': 269692.0}, 'BLK02_12326': {'bp': 131111.0, 'sum': 291075.0}, 'ProcedureBlank_11674': {'bp': 121975.0, 'sum': 275160.0}, 'BLK02_12199': {'bp': 121897.0, 'sum': 276003.0}, '11_posi_12409': {'bp': 158326.0, 'sum': 307267.0}, '10_posi_11484': {'bp': 154445.0, 'sum': 317629.0}, '17_posi_11464': {'bp': 150736.0, 'sum': 306121.0}, '12_posi_12134': {'bp': 149691.0, 'sum': 305297.0}, '16_posi_12407': {'bp': 147702.0, 'sum': 292984.0}, 'ProcedureBlank_11171': {'bp': 129439.0, 'sum': 289707.0}, 'BLK02_11255': {'bp': 128323.0, 'sum': 311516.0}, 'ProcedureBlank_11507': {'bp': 122472.0, 'sum': 289994.0}, '1_posi_11801': {'bp': 111984.0, 'sum': 250963.0}, '16_posi_11843': {'bp': 145881.0, 'sum': 299207.0}, '14_posi_12491': {'bp': 139091.0, 'sum': 285844.0}, 'ProcedureBlank_11883': {'bp': 134326.0, 'sum': 293050.0}, '14_posi_11087': {'bp': 132994.0, 'sum': 270423.0}, 'BLK02_11168': {'bp': 104421.0, 'sum': 286334.0}, '18_posi_11171': {'bp': 147789.0, 'sum': 311867.0}, '1_posi_12473': {'bp': 135200.0, 'sum': 311631.0}, '5_posi_11377': {'bp': 119621.0, 'sum': 230332.0}, 'ProcedureBlank_12491': {'bp': 147160.0, 'sum': 308692.0}, 'ProcedureBlank_11402': {'bp': 119766.0, 'sum': 258994.0}}
COMMENT: RETENTION_TIME_STDEV 0.845
COMMENT: PRECURSOR_M/Z_RAW 145.096786
COMMENT: PRECURSOR_M/Z_STDEV 0.000048
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.180; C6H12N2O2; [M+H]+; delta(ppm) -0.180443
COMMENT: PROPOSED_MF MS-FINDER 3.847; C6H12N2O2; [M+H]+; delta(ppm) -0.179697
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.042; C6H12N2O2; [M+H]+; delta(ppm) -0.179697
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H12N2O2; [M+H]+; delta(ppm) -0.179697
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.183; C6H12N2O2; [M+H]+; delta(ppm) -0.179697
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.099; C4H10N5O; [M+H]+; delta(ppm) 9.073936
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H12N2O2; [M+H]+; delta(ppm) -0.179697
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.156; WNYIBZHOMJZDKN-UHFFFAOYSA-N; [M+H]+; CC(O)=NCCN=C(C)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.781; RSEYNCRBFVVSDY-CGXWXWIYSA-N; [M+H]+; CCC\C(=N/O)\C(\C)=N/O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.583; WRJZKSHNBALIGH-UHFFFAOYSA-N; [M+H]+; C1CN(CCN1)CC(=O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.571; NQNQKLBWDARKDG-UHFFFAOYSA-N; [M+H]+; NC1CCN(CC1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.468; GPAZDGSPDSORHT-UHFFFAOYNA-N; [M+H]+; NC(=O)C1CC(O)CCN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.094; WRJZKSHNBALIGH-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-ylacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.033; GJTUWWUXLICYQX-UHFFFAOYSA-N; [M+H]+; UNPD76692
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.973; XDEFUBWPXAOAME-KWMWABLQNA-N; [M+H]+; UNPD88935
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.959; ZELPFFKOULVLMW-MAECEALJNA-N; [M+H]+; (3R,5R)-5-amino-3-methyl-D-proline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.894; NQNQKLBWDARKDG-UHFFFAOYSA-N; [M+H]+; 4-Amino-1-piperidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.887; GVNWZKBFMFUVNX-UHFFFAOYSA-N; [M+H]+; Adipamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.876; WNYIBZHOMJZDKN-UHFFFAOYSA-N; [M+H]+; N,N'-ethylenedi(diacetamide)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.854; NAIMNAZWFGBUDM-MLHKIVSYNA-N; [M+H]+; UNPD547
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.842; KBJPBSNKRUDROY-UHFFFAOYSA-N; [M+H]+; N-carbamoyl-3-methylbutanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.838; GPAZDGSPDSORHT-UHFFFAOYNA-N; [M+H]+; p-Hydroxypipecolamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.616; RSEYNCRBFVVSDY-CGXWXWIYSA-N; [M+H]+; UNPD109314
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RSEYNCRBFVVSDY-CGXWXWIYSA-N; [M+H]+; UNPD109314
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.974; WNYIBZHOMJZDKN-UHFFFAOYSA-N; [M+H]+; N,N'-ethylenedi(diacetamide)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.902; GVNWZKBFMFUVNX-UHFFFAOYSA-N; [M+H]+; Adipamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.804; NAIMNAZWFGBUDM-MLHKIVSYNA-N; [M+H]+; UNPD547
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.782; GPAZDGSPDSORHT-UHFFFAOYNA-N; [M+H]+; p-Hydroxypipecolamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.769; KBJPBSNKRUDROY-UHFFFAOYSA-N; [M+H]+; N-carbamoyl-3-methylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.759; WRJZKSHNBALIGH-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-ylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.731; ZELPFFKOULVLMW-MAECEALJNA-N; [M+H]+; (3R,5R)-5-amino-3-methyl-D-proline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.719; NQNQKLBWDARKDG-UHFFFAOYSA-N; [M+H]+; 4-Amino-1-piperidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.689; XDEFUBWPXAOAME-KWMWABLQNA-N; [M+H]+; UNPD88935
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.553; GJTUWWUXLICYQX-UHFFFAOYSA-N; [M+H]+; UNPD76692
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.244; GVNWZKBFMFUVNX-UHFFFAOYSA-N; [M+H]+; hexanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.669; DPYMAXOKJUBANR-UHFFFAOYSA-N; [M+H]+; 2,6-dimethyl-4-nitrosomorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.604; BRWAZZQVWBDAER-UHFFFAOYSA-N; [M+H]+; cyclohexyl-hydroxyimino-oxidoazanium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.347; BWRNWWSQZROEOA-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.307; WNYIBZHOMJZDKN-UHFFFAOYSA-N; [M+H]+; N-(2-acetamidoethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.272; ZCDDZFXNXKTHTN-SREVYHEPSA-N; [M+H]+; (3Z)-4-(dimethylamino)-3-hydroxyiminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; SJSZBOAQWPKFMU-UHFFFAOYSA-N; [M+H]+; N-(1-acetamidoethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; JOFDGSQZWZFPJC-UHFFFAOYSA-N; [M+H]+; N-methylmorpholine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.217; XLZZCQLWBSKIMI-UHFFFAOYSA-N; [M+H]+; 2-morpholin-2-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.214; XAQWCVPBQWSGPA-UHFFFAOYSA-N; [M+H]+; N-(4-formamidobutyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.195; WRJZKSHNBALIGH-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-ylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; SVLUODRIGFJEJZ-UHFFFAOYSA-N; [M+H]+; N-(2-oxopropyl)-N-propylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; KAUZNTPQLJGNNT-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-3-yloxyacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; KHABBYNLBYZCKP-UHFFFAOYSA-N; [M+H]+; 4-aminopiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; DATNNHYYNQOZPN-UHFFFAOYSA-N; [M+H]+; 1-hydroxypiperidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; IKNPVOCSVYGOLC-UHFFFAOYSA-N; [M+H]+; 2-amino-1-morpholin-4-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; SNUUBCVNJIAAML-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyethyl)-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; DPUICVIJDAOKBK-UHFFFAOYSA-N; [M+H]+; 4-(2-hydroxyethyl)piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; BWKWNLMXXRCEPL-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxyethyl)piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; MWBJZODENFIFCL-UHFFFAOYSA-N; [M+H]+; N'-hydroxyoxane-4-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; WDDZPNJQWYESGP-UHFFFAOYSA-N; [M+H]+; N-(2-aminoethyl)-3-oxobutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; YXNUSEWANCQVMM-UHFFFAOYSA-N; [M+H]+; 3-(hydroxymethyl)-1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.064; DKNWKLHLKDFWLZ-UHFFFAOYSA-N; [M+H]+; 2-ethoxycyclopropane-1-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.064; ITNIYAZQMKVHLI-WHFBIAKZSA-N; [M+H]+; (2S,4S)-4-methoxypyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.064; SYWUNSHVPNKQAL-UHFFFAOYSA-N; [M+H]+; 1-amino-3-methoxycyclobutane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; HEBUQYLWIJUFTB-UHFFFAOYSA-N; [M+H]+; 1-(2-hydroxypropyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; XFPMEDCHIXBNAS-UHFFFAOYSA-N; [M+H]+; 2-cyclobutyloxy-N'-hydroxyethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; XUBOALYMWZGFAU-UHFFFAOYSA-N; [M+H]+; 1-(1-hydroxypropan-2-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; YKZWLZLFBNIZCC-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; ADSDZFMVJUXKQY-UHFFFAOYSA-N; [M+H]+; (1-nitrosopiperidin-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; VGEOCVZKPBSYQC-UHFFFAOYSA-N; [M+H]+; 2-piperazin-2-ylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; UBBSHXCLOFHQHW-UHFFFAOYSA-N; [M+H]+; oxane-4-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; RUBROIIGKQNJPQ-UHFFFAOYSA-N; [M+H]+; 4-hydroxypiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; OBOQJPQGKZQKEM-UHFFFAOYSA-N; [M+H]+; oxane-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; AKFYOJKEXXUGPN-UHFFFAOYSA-N; [M+H]+; oxane-2-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; GRLWXERNPGKSAG-UHFFFAOYSA-N; [M+H]+; 1-(2-aminooxyethyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; RMVNTKIBJXAKNL-UHFFFAOYSA-N; [M+H]+; 5-methyloxolane-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.010; CCOAGJXNPXLMGI-UHFFFAOYSA-N; [M+H]+; 1-methylpiperazine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; WKCQWWYEUQLEJW-UHFFFAOYSA-N; [M+H]+; oxolan-2-ylmethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; FMPLMLGQGLTMRJ-UHFFFAOYSA-N; [M+H]+; methyl N-pyrrolidin-3-ylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; UZCCKSNAZAENAY-UHFFFAOYSA-N; [M+H]+; methyl N-(azetidin-2-ylmethyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; BQKQOQWBNFEUTB-BYPYZUCNSA-N; [M+H]+; (4S)-4-(aminomethyl)-5,5-dimethyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; GIQLCQSZZQXKAS-UHFFFAOYSA-N; [M+H]+; 4-aminooxane-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; MJXBRSNXTFSIDJ-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(oxolan-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; ATAMJEVMIZHZLI-UHFFFAOYSA-N; [M+H]+; 3-aminooxane-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; ALVGELMENIUCSV-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(oxolan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; MKQVGPSDKGPFJQ-UHFFFAOYSA-N; [M+H]+; 3-aminopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; IUNRHKPPQLCTGF-RFZPGFLSSA-N; [M+H]+; (2R,4R)-4-aminopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.998; ACXDLATWGZUBGD-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,2-oxazolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; QVUZNVSNHYYLRC-UHFFFAOYSA-N; [M+H]+; N-ethyl-3-hydroxyazetidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; KKIWLGAMEWOSQL-UHFFFAOYSA-N; [M+H]+; N-nitroso-N-propylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; REFUCZDQFDBMIC-UHFFFAOYSA-N; [M+H]+; N-methyl-N-(2-oxopentyl)nitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; ONWXKZSATLYJLX-UHFFFAOYSA-N; [M+H]+; 4-hydroxypiperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; AKFTYWINLIAFIX-UHFFFAOYSA-N; [M+H]+; 3-hydroxypiperidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.958; LRWYTBLXDHLWQW-UHFFFAOYSA-N; [M+H]+; azetidin-3-yl N-ethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; YFDRAVVFENWUHT-UHFFFAOYSA-N; [M+H]+; 6-(aminomethyl)-4-methylmorpholin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; ZPJZSEHCMJYUPI-UHFFFAOYSA-N; [M+H]+; methyl piperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; NENLJFGOBLUMHH-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-3-ethyl-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; KEKCWYPJIFEYDP-UHFFFAOYSA-N; [M+H]+; 3-(2-methoxyethyl)imidazolidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; TZRKYCCNZAAKMF-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-4-methylmorpholin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; ODQZNBWVRPKMKN-UHFFFAOYSA-N; [M+H]+; methyl piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; ROBPISXCCHKNSO-UHFFFAOYSA-N; [M+H]+; methyl 3-(aminomethyl)azetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; XHQWSUCHPAVLNQ-UHFFFAOYSA-N; [M+H]+; 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; WFLQKKAOJXSPIK-UHFFFAOYSA-N; [M+H]+; ethyl 4-amino-4-iminobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; DOXJSTOBGXLIKS-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)morpholin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; RKLOBJQVKXENDO-UHFFFAOYSA-N; [M+H]+; 3-[2-(methylamino)ethyl]-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; CGWMNQRJDFNOCF-UHFFFAOYSA-N; [M+H]+; 3-(3-aminopropyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; FTQJIMMAQDHBRD-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-1,3-oxazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; WFWJBRITXFDOBA-UHFFFAOYSA-N; [M+H]+; azetidin-3-yl N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.581; GPTHYJZLMPEXPV-RXMQYKEDSA-N; [M+H]+; methyl (2R)-1-aminopyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.564; ASBYNUPWDRZDBR-UHFFFAOYSA-N; [M+H]+; diethyl ethanediimidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -63.104; WNYIBZHOMJZDKN; [M+H]+; 1,2-ethylenebisacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.016; FFYAVOJIYAAUNX; [M+H]+; NN''-Diethyloxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.086; XAQWCVPBQWSGPA; [M+H]+; N-(4-formamidobutyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.953; GVNWZKBFMFUVNX; [M+H]+; Adipamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.878; DDPOPNULNSDSKL; [M+H]+; N,N''-Dipropionylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.879; WDDZPNJQWYESGP; [M+H]+; N-(2-aminoethyl)-3-oxobutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.683; YKZWLZLFBNIZCC; [M+H]+; ACMC-20mndk
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.414; VHCVPWSUVMHJLL; [M+H]+; Propionamide, L-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.722; SVLUODRIGFJEJZ; [M+H]+; beta-Oppn
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.071; GPAZDGSPDSORHT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.607; YRLZLSUWKDDOAR; [M+H]+; 1-nitrosoazepan-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.719; WRJZKSHNBALIGH; [M+H]+; 2-piperazin-1-ylacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.981; PRMCBQFBVZGCIA; [M+H]+; N,N'',2-trimethylpropanediamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.361; KKIWLGAMEWOSQL; [M+H]+; 1-Oxopropylpropylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.270; NQNQKLBWDARKDG; [M+H]+; 4-aminopiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.437; ZPJZSEHCMJYUPI; [M+H]+; Methy piperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.733; DFTMMVSDKIXUIX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.162; SUEKHOACTNFEKG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.516; FFNJWARKMJTPJP; [M+H]+; (Z)-4,5-diaminohex-4-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.431; RUBROIIGKQNJPQ; [M+H]+; 4-hydroxypiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.572; KNWWGBNAUNTSRV; [M+H]+; Mepipca
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.032; XUBOALYMWZGFAU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.059; HEBUQYLWIJUFTB; [M+H]+; 2-Imidazolidinone, 1-(2-hydroxypropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.269; AEEHNHHXHZWHGB; [M+H]+; 1-nitrosoazepan-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.604; AVDSWVVJESAEQH; [M+H]+; 2-amino-N-(1-oxopropan-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.856; RSEYNCRBFVVSDY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.992; DPYMAXOKJUBANR; [M+H]+; Dimethylnitrosomorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.115; ASBYNUPWDRZDBR; [M+H]+; Diethyl oximidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.956; NJTMPILFXWNYAH; [M+H]+; 1-(Pivaloyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.114; IQBWACPVFGQZNN; [M+H]+; (4S)-4-amino-N-methyl-5-oxopentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.062; LXCJGJYAOVCKLO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.447; XDEFUBWPXAOAME; [M+H]+; Dehydrolysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.626; BLKNAFAMNSXQRW; [M+H]+; (E)-2,6-diaminohex-3-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.474; NLJASJZSFGKTQT; [M+H]+; 2-Propanol, 1-(allylnitrosamino)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.992; REFUCZDQFDBMIC; [M+H]+; 1-(Methylnitrosamino)-2-pentanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.528; ZELPFFKOULVLMW; [M+H]+; (3R,5R)-5-amino-3-methyl-D-proline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.321; XFPMEDCHIXBNAS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.394; GJTUWWUXLICYQX; [M+H]+; Tetramethyloxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.087; NAIMNAZWFGBUDM; [M+H]+; 2-methoxypyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.266; JJQQBAOLCFGQJG; [M+H]+; 3-butan-2-yloxadiazolidin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.261; KBJPBSNKRUDROY; [M+H]+; (3-methylbutyryl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.197; GTNIOVHJFHUJMS; [M+H]+; 4-hydroxy-5,5-dimethyl-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -317.990; GBOGEEQLPKNDRP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.812; ZCDDZFXNXKTHTN; [M+H]+; Izonitrozine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.437; XHQWSUCHPAVLNQ; [M+H]+; Hexahydrofuro[3,2-b]furan-3,6-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.619; WNYIBZHOMJZDKN; [M+H]+; 1,2-ethylenebisacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -51.468; WNYIBZHOMJZDKN; [M+H]+; N-(2-acetamidoethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.502; FFYAVOJIYAAUNX; [M+H]+; N,N'-Diethyloxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.435; DFTMMVSDKIXUIX; [M+H]+; 3-N,4-N-dioxidohexane-3,4-diimine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.051; XAQWCVPBQWSGPA; [M+H]+; N,N'-Tetramethylenebis(formamide)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.952; DDPOPNULNSDSKL; [M+H]+; N'-Propionylpropionohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.554; VHCVPWSUVMHJLL; [M+H]+; (2R)-2-acetamido-N-methylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.550; PRMCBQFBVZGCIA; [M+H]+; N,N',2-trimethylpropanediamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.514; WDDZPNJQWYESGP; [M+H]+; N-(2-Aminoethyl)-3-oxobutyramide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -166.926; GVNWZKBFMFUVNX; [M+H]+; hexanediamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -169.104; RSEYNCRBFVVSDY; [M+H]+; N-[2-(hydroxyimino)hexan-3-ylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.782; WNYIBZHOMJZDKN; [M+H]+; N-(2-acetamidoethyl)acetamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, N,N'-ethylenedi(diacetamide), WNYIBZHOMJZDKN-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (7), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (5);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H12N2O2
CH$EXACT_MASS: 144.089878
CH$SMILES: CC(=O)NCCNC(=O)C
CH$IUPAC: InChI=1S/C6H12N2O2/c1-5(9)7-3-4-8-6(2)10/h3-4H2,1-2H3,(H,7,9)(H,8,10)
CH$NAME: N,N'-ethylenedi(diacetamide)
CH$NAME: N-(2-acetamidoethyl)acetamide
CH$LINK: INCHIKEY WNYIBZHOMJZDKN-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:70097
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 23.742
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 145.097128
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9500000000-039b4856d9c94fa9579c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0490967 60.3992 71.049710 1.1541 14.23 0.0704 164 f{C4H7O1}/-0.63ppm,p-C2H6N2O1
  72.0443335 47.6508 72.044940 1.4574 12.01 0.0415 162 f{C3H6N1O1}/-0.79ppm,p-C3H7N1O1
  85.0759908 30.9147 85.076470 1.9747 7.37 0.2521 130 f{C4H9N2}/-0.40ppm,p-C2H4O2
  86.0600533 999.0000 86.060520 0.3137 0.00 0.1924 165 f{C4H8N1O1}/0.15ppm,p-C2H5N1O1
  99.0440705 32.3670 99.044400 1.8174 9.34 -0.1513 123 f{C5H7O2}/0.15ppm,p-C1H6N2
  109.1012233 32.4550 109.101460 2.7131 8.02 -0.0887 127 ?
  127.0866174 183.0905 127.086630 0.9914 37.87 0.4943 165 f{C6H11N2O1}/0.22ppm,p-H2O1
  127.1119778 80.8612 127.111990 2.6512 18.03 -0.0542 163 ?
  128.0706518 102.7485 128.070650 1.4679 15.60 0.0146 165 f{C6H10N1O2}/0.37ppm,p-H3N1
  145.0970390 313.4330 145.096940 0.7995 63.76 1.0000 165 f{C6H13N2O2}/-0.79ppm,p
PK$NUM_PEAK: 10
PK$PEAK: m/z int. rel.int.
  71.049097 60.40 60
  72.044333 47.65 47
  85.075991 30.91 30
  86.060053 999.00 999
  99.044070 32.37 32
  109.101223 32.45 32
  127.086617 183.09 183
  127.111978 80.86 80
  128.070652 102.75 102
  145.097039 313.43 313
//
